Obstructive sleep apnea in the obese.
Obstructive sleep apnea (OSA) syndrome occurs in 4% to 9% of middle-aged men and in 1% to 2% of middle-aged women. The incidence of OSA among morbidly obese patients is 12- to 30-fold higher. The pathophysiology of OSA is complex and incompletely understood. The important clinical symptoms of OSA include snoring, daytime sleepiness, restless sleep, morning fatigue, and headaches. The diagnosis is made by polysomnography. The possible sequelae of OSA are hypertension, left and right ventricular hypertrophy, sudden cardiovascular death, and increased risk for brain infarction. Nasal continuous positive airway pressure (nCPAP) appears to be the recommended treatment for OSA. Morbidly obese patients may also benefit from weight reduction gastric surgery.
Kyzer
S
S
Department of Surgery B, E. Wolfson Medical Center, Holon, Israel.
Charuzi
I
I
D006801:Humans; D009767:Obesity, Morbid / Q000150:complications*; D012891:Sleep Apnea Syndromes / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy